Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Contributions to magnetic susceptibility of brain tissue.
Gamified Design for Health Workshop.
Positive correlation between functional disability, excessive daytime sleepiness, and fatigue in relapsing-remitting multiple sclerosis.
Absence of Tau triggers age-dependent sciatic nerve morphofunctional deficits and motor impairment.
Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function.
Prognostic factors associated with long-term disability and secondary progression in patients with Multiple Sclerosis.
Correlation of MRI findings and cognitive function in multiple sclerosis patients using montreal cognitive assessment test.
Reduced fecal GABA levels in multiple sclerosis patients.
Lubrini et al.'s study, "The contribution of depressive symptoms to slowness of information processing in relapsing remitting multiple sclerosis".
Prothrombin and factor X are elevated in multiple sclerosis patients.
Vitamin D status in patients with MS is negatively correlated with depression, but not with fatigue.
Molecular and genetic requirements for preferential recruitment of TCRBV8S2+ T cells in Lewis rat experimental autoimmune encephalomyelitis.
Pathoetiology of multiple sclerosis: are we barking up the wrong tree?
Response to "Vitamin D status is negatively correlated with retinal nerve fiber layer thickness in relapsing-remitting MS patients without acute optic neuritis" by Knippenberg et al.
Inflammation at the blood-brain barrier: The role of liver X receptors.
Using mixed methods case-series evaluation in the development of a guided self-management hybrid CBT and ACT intervention for multiple sclerosis pain.
Ratiometric analysis of in vivo retinal layer thicknesses in multiple sclerosis.
Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?
Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis.
Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting.
Relevance of biomarkers in disease progression in multiple sclerosis.
Safety, Tolerability, and Immunogenicity of Interferons.
Statins: a revised appraisal for potential additional future treatment indications.
Is my MS patient failing treatment?
Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis.

Pages